Ernesto Diaz is a highly skilled Data Scientist at the University of California, San Francisco (UCSF), specializing in Hyperpolarized Carbon-13 Metabolic Imaging within the Department of Radiology and Biomedical Imaging. He earned his Bachelor of Science in Computer Science from San Francisco State University in 2022, consistently achieving Dean’s List honors.
-
The genomic landscape of hypodiploid acute lymphoblastic leukemia
L. Holmfeldt, L. Wei, E. Diaz-Flores, M. Walsh, J. Zhang, L. Ding, …
Nature Genetics, 45(3), 242-252, 2013. (Citations: 841)
-
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
N. Kotecha, N.J. Flores, J.M. Irish, E.F. Simonds, D.S. Sakai, S. Archambeault, …
Cancer Cell, 14(4), 335-343, 2008. (Citations: 290)
-
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
V. Frismantas, M.P. Dobay, A. Rinaldi, J. Tchinda, S.H. Dunn, J. Kunz, …
Blood, The Journal of the American Society of Hematology, 129(11), e26-e37, 2017. (Citations: 240)
-
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Z. Zhao, J. Zuber, E. Diaz-Flores, L. Lintault, S.C. Kogan, K. Shannon, …
Genes & Development, 24(13), 1389-1402, 2010. (Citations: 211)
-
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
J.O. Lauchle, D. Kim, D.T. Le, K. Akagi, M. Crone, K. Krisman, K. Warner, …
Nature, 461(7262), 411-414, 2009. (Citations: 156)
-
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells
M.E.M. Van Meter, E. Díaz-Flores, J.A. Archard, E. Passegué, J.M. Irish, …
Blood, 109(9), 3945-3952, 2007. (Citations: 138)
-
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial
N. Jain, E. Curran, N.M. Iyengar, E. Diaz-Flores, R. Kunnavakkam, …
Clinical Cancer Research, 20(2), 490-498, 2014. (Citations: 133)
-
Bcl-2 is a therapeutic target for hypodiploid B-lineage acute lymphoblastic leukemia
E. Diaz-Flores, E.Q. Comeaux, K.L. Kim, E. Melnik, K. Beckman, K.L. Davis, …
Cancer Research, 79(9), 2339-2351, 2019. (Citations: 80)
-
Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism
I. Flores, D.R. Jones, A. Ciprés, E. Díaz-Flores, M.A. Sanjuan, I. Mérida
The Journal of Immunology, 163(2), 708-714, 1999. (Citations: 71)
-
Regulation of diacylglycerol kinase α by phosphoinositide 3-kinase lipid products
A. Ciprés, S. Carrasco, E. Merino, E. Díaz, U.M. Krishna, J.R. Falck, …
Journal of Biological Chemistry, 278(37), 35629-35635, 2003. (Citations: 69)
-
Targeting oncogenic ras
E. Diaz-Flores, K. Shannon
Genes & Development, 21(16), 1989-1992, 2007. (Citations: 65)
-
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis
Z. Zhao, C.C. Chen, C.D. Rillahan, R. Shen, T. Kitzing, M.E. McNerney, …
Nature Genetics, 47(5), 539-543, 2015. (Citations: 48)
-
Abnormal hematopoiesis in Gab2 mutant mice
Y. Zhang, E. Diaz-Flores, G. Li, Z. Wang, Z. Kang, E. Haviernikova, S. Rowe, …
Blood, 110(1), 116-124, 2007. (Citations: 48)
-
β2-chimaerin provides a diacylglycerol-dependent mechanism for regulation of adhesion and chemotaxis of T cells
M. Siliceo, D. García-Bernal, S. Carrasco, E. Díaz-Flores, F.C. Leskow, …
Journal of Cell Science, 119(1), 141-152, 2006. (Citations: 48)
-
Membrane translocation of protein kinase Cθ during T lymphocyte activation requires phospholipase C-γ-generated diacylglycerol
E. Díaz-Flores, M. Siliceo, C. Martínez-A, I. Mérida
Journal of Biological Chemistry, 278(31), 29208-29215, 2003. (Citations: 48)
-
Rapid screening of COVID‐19 patients using white blood cell scattergrams, a study on 381 patients
J. Osman, J. Lambert, M. Templé, F. Devaux, R. Favre, C. Flaujac, D. Bridoux, …
British Journal of Haematology, 190(5), 718-722, 2020. (Citations: 34)
-
NRAS G12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia
Z. Sachs, R.S. LaRue, H.T. Nguyen, K. Sachs, K.E. Noble, N.A. Mohd Hassan, …
Blood, 124(22), 3274-3283, 2014. (Citations: 30)
-
PLC-γ and PI3K link cytokines to ERK activation in hematopoietic cells with normal and oncogenic Kras
E. Diaz-Flores, H. Goldschmidt, P. Depeille, V. Ng, J. Akutagawa, K. Krisman, …
Science Signaling, 6(304), ra105-ra105, 2013. (Citations: 21)
-
Evolution of artificial intelligence-powered technologies in biomedical research and healthcare
E. Diaz-Flores, T. Meyer, A. Giorkallos
Smart Biolabs of the Future, 23-60, 2022. (Citations: 18)
-
Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency
Z. Sachs, R.A. Been, K.J. DeCoursin, H.T. Nguyen, N.A.M. Hassan, …
Haematologica, 101(10), 1190, 2016. (Citations: 18)